Using Mobile Phones to Improve Adherence to Inhaled Steroids (ADEPT4)

Rush

Status: Completed

Conditions: Asthma

Treatments: Behavioral: Beta2-adrenergic agonist Mobile Phone Application; Behavioral: Asthma Supervision; Behavioral: Inhaled Corticosteroid Mobile Phone Application; Behavioral: Mobile Phone

Study type: Interventional

Funder types: Other; Industry; NIH

Identifiers

NCT01710059

10010402

5K23HL092292-04 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This study has two main goals. The first goal is to test whether a mobile phone intervention can increase adherence to daily inhaled steroid medications in African American adolescents prescribed this type of medication by his/her asthma doctor. The second goal is to use a mobile phone intervention to better understand real life patterns of use of quick-relief (beta2-adrenergic agonist) asthma medication in this population.

Enrollment: 12 patients

Sex: All

Ages: 11 to 16 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 11-16 years of age
• self-identify as African American
• have persistent asthma
• be on a prescription daily inhaled corticosteroid medication for asthma
• be on a prescription inhaled beta2-adrenergic agonist medication for asthma

Exclusion criteria

• candidate refusal
• the presence of other co-morbidities that could interfere wtih study participation
• > 60% adherence to inhaled corticosteroid medication, measured by the electronic dose counter, during the run-in period

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

12 participants in 1 patient group

Experimental: Intervention Group

Experimental group

Description:

Experimental: Intervention Group 1) Asthma Supervision; 2) Mobile Phone with talking, texting, and data plan; 3) Inhaled Corticosteroid Mobile Phone Application to provide virtual doctor supervision, immediate feedback, and positive reinforcement for taking inhaled corticosteroid medication as indicated; and 4) Beta2-adrenergic agonist Mobile Phone Application to monitor real time patterns of use of beta2-adrenergic agonist medication for asthma.

Treatment:

Behavioral: Asthma Supervision

Behavioral: Beta2-adrenergic agonist Mobile Phone Application

Behavioral: Mobile Phone

Behavioral: Inhaled Corticosteroid Mobile Phone Application